APRES(redirected from Angiotensin-converting enzyme inhibition Post REvascularization Study)
Also found in: Dictionary.
APRESAngiotensin-converting enzyme inhibition Post REvascularization Study. A trial assessing ramipril’s effect, if any, on the incidence of cardiac events after revascularisation in patients with angina and LVEF of 30% to 50%.
Primary endpoint Composite of cardiac death, nonfatal acute myocardial infarction, development of clinical heart failure or recurrent angina.
Conclusions Long-term ramipril after invasive revascularisation significantly reduces the composite end point.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
APRESCardiology A clinical trial–Angiotensin-converting enzyme inhibition Post REvascularization Study
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.